EXCHANGE TRADED CONCEPTS, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$888,000
-1.3%
20,169
+10.5%
0.03%
-17.6%
Q1 2021$900,000
+202.0%
18,253
+157.8%
0.03%
+142.9%
Q4 2020$298,000
-3.6%
7,079
+4.8%
0.01%
-17.6%
Q3 2020$309,0006,7550.02%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,055,719$35,367,00012.68%
GREAT POINT PARTNERS LLC 828,253$27,746,0005.70%
McClain Value Management LLC 116,153$3,891,0004.80%
Stonepine Capital Management, LLC 231,913$7,769,0004.63%
ARMISTICE CAPITAL, LLC 228,000$7,638,0001.81%
Opaleye Management Inc. 90,000$3,015,0001.78%
Matarin Capital Management, LLC 257,268$8,618,478,0000.97%
HAYS ADVISORY LLC 116,939$3,917,0000.87%
Granahan Investment Management 496,025$16,617,0000.57%
AlphaMark Advisors, LLC 33,000$1,106,0000.57%
View complete list of ENANTA PHARMACEUTICALS INC shareholders